Dear AcceGen Customers,

Due to the recent COVID-19 pandemic, order shipment, processing times, and company hours may be affected. However, we are trying our best to provide high-quality products and services as usual. Thank you for your patience and continuous support. The health and safety of our customers and employees is always the highest priority for us. Need any support? Contact us at info@accegen.com.

X

Home > Products > Adult Stem Cells >

HighQC™ Human Cord Blood CD34/CD133+ Progenitor Cells

Product Name

HighQC™ Human Cord Blood CD34/CD133+ Progenitor Cells

Cat.No

ABC-SC0084T

Product Type

Human Adult Stem Cells

Species

Human

Size/Quantity

1 vial

Shipping Info

Dry Ice

Storage

Liquid Nitrogen

Description

CD34 is a well-known marker for primitive and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial progenitors. AcceGen offers CD34+ progenitor cells in a phenotypically undifferentiated state. The progenitor cells are derived from cord blood of healthy donors and produced at the AcceGen facility. Progenitor cells contain two main cellular subpopulations, hematopoietic and endothelial progenitor cells. CD34+ progenitor cells are suitable for a series of studies for directed differentiation into more committed types of blood cells and endothelial lineages. Immediately after isolation, the freshly prepared CD34+ progenitor cells are cryopreserved using a serum-free freezing medium.

Samples from each donor are tested via PCR to confirm non-reactivity.

Cord blood CD133+ cells are isolated using direct positive immunomagnetic selection for CD133+ cells. The majority of CD133+ cells also express CD34. CD133 is a glycoprotein with sub-cellular localization in plasma membrane protrusions. In humans, this protein was originally identified as an antigenic marker expressed on hematopoietic stem cells. In addition, these cells are highly proliferative primitive hematopoietic progenitors. They can give rise to mature terminally differentiated hematopoietic cells by means of directed differentiation.

AcceGen offers CD133 cells in a phenotypically undifferentiated state. The cells are derived from fresh cord blood of healthy donors and produced at the AcceGen facility. Immediately after isolation, the freshly prepared CD133 cells are cryopreserved using a serum-based cryopreservation medium. Each vial contains 100,000 cells per vial.

Source Organ

Human Stem Cell Collection

Citation Guide

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $410 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

For research use only

Product Image AcceGen Frozen Cells & Cell Lines
  • ONLINE INQUIRY
  • PRODUCT REVIEWS
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time?

Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Privacy Policy: AcceGen will never sell, rent, or share your personal information with any third parties without your express permission.
Reviews of HighQC™ Human Cord Blood CD34/CD133+ Progenitor Cells
AcceGen is always trying to do right by our customers and working hard to build a higher quality product.

Your email address will not be published.

AcceGen Scroll Top Button
Copy link